Angiex Company
Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2015
Employees Number:
1-10
Funding Status:
Early Stage Venture
Total Funding:
32880022
Estimated Revenue:
Less than $1M
Last Funding Type:
Series B
Register and Claim Ownership